Department for Digital, Culture, Media and Sport

Culture Investment Fund

lord bird: To ask Her Majesty's Government what proportion, and what amount, of the £250 million Culture Investment Fund will be allocated specifically to libraries

baroness barran: Over £125m of this new funding will be invested in regional museums and libraries around the country over five years from 2020/21. The funding will be used to upgrade buildings and technology so public libraries across England are better placed to respond to the changing ways people are using them. Details of investment plans will be set out in due course.

Legislation: Internet

lord tyler: To ask Her Majesty's Government how many revisions to Legislation.gov.uk have yet to be made in relation to (1) primary, and (2) secondary legislation; and what are those revisions.

baroness barran: 99.1% of Primary legislation on legislation.gov.uk is up to date. There are 45,000 amendments (to the nearest 1000) remaining. For secondary legislation, the current policy is to update documents made from January 2018 onwards, and there are approximately 3,200 amendments to be made. Full details of all of these amendments are publically available and can be found by using the Changes to Legislation search at www.legislation.gov.uk/changes.

Legislation: Internet

lord tyler: To ask Her Majesty's Government whether Legislation.gov.uk makes use of (1) Google Analytics, or (2) any similar tools; and what personal data is collected by Legislation.gov.uk.

baroness barran: Legislation.gov.uk does make use of Google Analytics. Usage log file data is processed using the Kibana software. No personal data is collected by the www.legislation.gov.uk website. Further information is provided in the attached Legislation.gov.uk privacy policy, which can also be found at www.legislation.gov.uk/privacynotice.

Department for Education

Free Schools

lord hunt of kings heath: To ask Her Majesty's Government how many schools which were approved in wave 9 of the free schools programme are (1) under construction, and (2) open.

lord hunt of kings heath: To ask Her Majesty's Government how many of the schools approved in wave 10 of the free schools programme are (1) under construction and (2) open.

lord hunt of kings heath: To ask Her Majesty's Government how many of the schools approved in wave 11 of the free schools programme are (1) under construction and (2) open.

lord hunt of kings heath: To ask Her Majesty's Government how many of the schools approved in wave 12 of the free schools programme are (1) under construction and (2) open.

lord hunt of kings heath: To ask Her Majesty's Government how many of the schools approved in wave 13 of the free schools programme are (1) under construction and (2) open.

lord agnew of oulton: Since 2010, the government has funded thousands of good new school places across the country through the free schools programme. The programme aims to kick-start wider improvement, inject fresh approaches and draw in talent from a variety of backgrounds. As at 1 October 2019 there are 507 open free schools, 48 university technical colleges and 24 studio schools, which will provide over 320,000 places when at capacity. The attached table contains the information requested. The length of time it takes to identify, acquire and adapt the right site can sometimes mean that it is necessary for a school to open in temporary accommodation to meet the need for school places in the local area. As such, a free school can open whilst works are taking place on the permanent site. Where we have had concerns over the long-term success and viability of a proposed school, we have taken swift and decisive action to cancel the project. On occasion, a trust will decide to withdraw a project before the proposed school opens. The primary objective of the department in all cases is to ensure the best possible educational outcomes for local pupils and to secure value for money for the taxpayer.



HL102_HL30_HL31_HL32_HL33_table
(PDF Document, 11.74 KB)

Department for Business, Energy and Industrial Strategy

Trade Marks: Internet

lord taylor of warwick: To ask Her Majesty's Government what plans they have tolegislate to ensurethat web search engines de-index (1) URLs or (2) websites from its web search indexwhentrademarkshave been infringed.

lord duncan of springbank: There are various options available to trade mark owners who believe their rights have been infringed online, and these range from injunctive web site blocking available through the courts, to voluntary cooperation between enforcement agencies and registrars such as Nominet to suspend domain names that are used for IP infringing activity. The government works closely with web search engines on a number of voluntary initiatives to tackle IP infringement of all kinds online.

Department of Health and Social Care

Fertility: Medical Treatments

baroness barker: To ask Her Majesty's Government what assessment they have made of the impact of the judgment in R (TT) v the Registrar General for England and Wales & Ors [2019] EWHC 2384 (Fam) on the (1) Human Fertilisation and Embryology Act 2008, and (2) regulation of fertility treatment by the Human Fertilisation and Embryology Authority.

baroness barker: To ask Her Majesty's Government what assessment they have made of the impact of the judgment in R (TT) v the Registrar General for England and Wales & Ors [2019] EWHC 2384 (Fam) on members of the trans community who wish to access fertility treatment at a licensed clinic.

baroness blackwood of north oxford: The Court found that the scheme of birth registration for the children of trans men is lawful and proportionate. The Government welcomes the Court’s decision.The Government’s view is that the judgment has no effect on the availability of regulated fertility treatment and will now consider whether there should be further guidance to clarify this position. The Government considers that regulated fertility treatment is currently, and will remain, equally available to all (trans) women and (trans) men under the Human Fertilisation and Embryology Acts.

Mental Capacity: Codes of Practice

baroness barker: To ask Her Majesty's Government when consultation on the Code of Practice issued under the Mental Capacity (Amendment) Act 2019 will commence.

baroness blackwood of north oxford: Following Royal Assent for the Mental Capacity (Amendment) Act 2019, the Department has been engaging across England and Wales with a range of key stakeholders from the health and social care sector and people with lived experience to co-produce the Code of Practice for the new Liberty Protection Safeguards. We plan to start public consultation in the new year and the Code will be laid before both Houses ahead of the new Liberty Protection Safeguards system coming into force.

Vancomycin

baroness masham of ilton: To ask Her Majesty's Government what information they hold on the availability of Vancomycin for the treatment of Clostridium difficile in pharmacies across the country.

baroness blackwood of north oxford: The Department fully understands that maintaining access to vancomycin for the treatment of Clostridium difficile is vitally important to many people in this country.We are aware that two manufacturers of vancomycin capsules are currently experiencing supply issues. However, alternative manufacturers have supplies available and there are sufficient supplies available to continue to meet normal United Kingdom demand.We continue to work closely with industry and partners in the health system to help prevent shortages and to ensure that the risks to patients are minimised when supply issues do arise.

Eating Disorders: Health Services

baroness parminter: To ask Her Majesty's Government, following their response to the Seventeenth Report of Session 2017–19 by the House of Commons Public Administration and Constitutional Affairs Committee (HC855) on 23 September, how many sites have been selected to "pump prime" innovative models of service for adults with eating disorders; and where those test sites will be.

baroness blackwood of north oxford: NHS England and NHS Improvement are providing ‘pump prime’ funding to 12 pilot sites over 2019/20 and 2020/21 to test and implement new models of integrated primary and community mental health care for adults and older adults with a range of severe mental illnesses. Eight of these will test models that include services for adult eating disorders, including:- Cambridgeshire and Peterborough Sustainability and Transformation Partnership;- Cheshire and Merseyside Sustainability and Transformation Partnership;- Herefordshire and Worcestershire Sustainability and Transformation Partnership;- Hertfordshire and West Essex Sustainability and Transformation Partnership;- North East London Sustainability and Transformation Partnership;- North West London Sustainability and Transformation Partnership;- Somerset Sustainability and Transformation Partnership; and- South Yorkshire and Bassetlaw Integrated Care SystemThese sites will work towards improving access to care for adults and older adults with eating disorders in line with published guidance from NHS England and NHS Improvement. They will also generate the first phase of learning about how to achieve greater levels of parity with children and young people’s eating disorder services over the course of the NHS Long Term Plan.

Health Services: British Nationals Abroad

lord taylor of warwick: To ask Her Majesty's Government what steps they intend to take to ensure the provision of healthcare for UK pensioners living in the European Union post-Brexit.

baroness blackwood of north oxford: The Government is committed to securing a deal with the European Union and is working in an energetic and determined way to achieve this.The United Kingdom Government has proposed to all Member States that we should maintain existing reciprocal healthcare arrangements, including the S1 scheme, until 31 December 2020 if the UK leaves the EU without a deal. These arrangements would safeguard healthcare for the hundreds of thousands of UK-insured persons who live in Europe.I laid a Written Ministerial Statement (HLWS1795) on 26 September 2019, setting out the Department’s progress on ‘no deal’ reciprocal healthcare arrangements, and updated information has been published online on the situation for each Member State, including what arrangements have been put in place. These pages will be kept updated as further assurances from Member States are received.

Bevacizumab

lord willis of knaresborough: To ask Her Majesty's Government why Avastin is not routinely made available on the NHS for certain groups of cancer patients.

baroness blackwood of north oxford: Most new medicines are assessed by the National Institute for Health and Care Excellence (NICE) which makes recommendations for the National Health Service on whether they represent a clinically and cost effective use of NHS resources. Since 2016, NICE makes recommendations for the NHS on all new licensed cancer medicines through its technology appraisal programme. NHS commissioners are legally required to fund treatments recommended in NICE technology appraisal guidance.NICE has appraised Avastin (bevacizumab) for use in the treatment of a number of different types of cancer and has unfortunately not been able to recommend it as a clinically and cost effective use of NHS resources for any type of cancer at the price offered by the drug company. Avastin is not therefore routinely funded by the NHS for any licensed indication.Avastin is funded as an off-label treatment for some types of cancer through the Cancer Drugs Fund.

Bevacizumab

lord willis of knaresborough: To ask Her Majesty's Government whether Avastin has approval from the European Medicines Authority to be used to treat cancer.

baroness blackwood of north oxford: Avastin has approval from the European Medicines Agency to be used to treat cancer in combination with specific chemotherapies in the advanced stages of several cancers. They are:- Metastatic colorectal cancer;- Metastatic breast cancer;- Certain types of unresectable advanced, metastatic or recurrent lung cancer;- Advanced or metastatic renal cell cancer;- Advanced or recurrent or resistant ovarian/fallopian tube cancer; and- Persistent or recurrent or metastatic cervical cancer.Full details of the indications that Avastin is licensed for can be found in the European public assessment report for Avastin. It explains how the Agency assessed the medicine to recommend its authorisation and its conditions of use and is publicly available on their website.

Bevacizumab

lord willis of knaresborough: To ask Her Majesty's Government whether there are (1) current applications, or (2) pending requests, for the use of Avastin following Phase 3 clinical trials.

baroness blackwood of north oxford: To extend the indication of Avastin, the Marketing Authorisation Holder (Roche Registration GmbH) would need to submit the results of relevant clinical trials and other information to the European Medicines Agency (EMA) to demonstrate acceptable safety and efficacy and a positive balance of benefit to risk. At present, as Avastin has a European Community Marketing Authorisation, a national submission to the Medicines and Healthcare products Regulatory Agency to extend the indication is not possible.There has not been any recent positive opinion from the EMA for a new indication of Avastin to be submitted to the European Commission and the EMA has not published any pending extension of indication applications.

Cancer: Transplant Surgery

lord willis of knaresborough: To ask Her Majesty's Government whether liver and bowel transplantation is currently approved by the National Institute for Health and Care Excellence for cancer patients; and if not, whether there are any clinical trials that have reached Phase 3.

baroness blackwood of north oxford: The National Institute for Health and Care Excellence has not produced any guidance relating to combined liver and bowel transplants for cancer patients.The Department funds research mainly through the National Institute for Health Research (NIHR). The usual practice of the NIHR and other research funders is not to ring-fence funds for expenditure on particular topics. The NIHR welcomes funding applications for research into any aspect of human health, including liver and bowel transplantation.There has been one relevant clinical trial that reached Phase 3:Study title: In open, prospective, single arm study investigating efficacy and safety of human hepatitis B immunoglobulin Zutectra in liver transplanted patients - the ZEUS Study.Date: 22 November 2012 – 10 April 2014

Essential Tremor: Magnetic Resonance Imagers

baroness golding: To ask Her Majesty's Government what plans they have for the funding of MRI treatment of essential tremor following the recommendation by NICE for its use.

baroness blackwood of north oxford: The National Institute for Health and Care Excellence (NICE) published interventional procedure (IP) guidance on the use of Magnetic Resonance Imaging (MRI)-guided focused ultrasound as a treatment for essential tremor in June 2018. A copy of Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor is attached.NICE concluded that the evidence on the safety of unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor raises no major safety concerns. However, current evidence on its efficacy is limited in quantity. Therefore, this procedure should not be used unless there are special arrangements for clinical governance, consent, and audit or research.IP guidance looks at procedures used for diagnosis or treatment. It considers if they are safe and work well enough for wider use in the National Health Service. Whilst compliance with IP guidance is not mandatory, it is considered best clinical practice for the NHS to take it into account.



MRI-essential-tremor
(PDF Document, 81.73 KB)